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Posttraumatic stress disorder (PTSD) and physical health problems, particularly somatic symptom disorder, are highly comorbid. Stud-
ies have only examined this co-occurrence at the disorder level rather than assessing the associations between specific symptoms. Us-
ing network analysis to identify symptoms that act as bridges between these disorders may allow for the development of interventions
to specifically target this comorbidity. We examined the association between somatization and PTSD symptoms via network analysis.
This included 349 trauma-exposed individuals recruited through the National Centre for Mental Health PTSD cohort who completed
the Clinician-Administered PTSD Scale for DSM-5 and the Patient Health Questionnaire–15. A total of 215 (61.6%) individuals met
the DSM-5 diagnostic criteria for PTSD. An exploratory graph analysis identified four clusters of densely connected symptoms within the
overall network: PTSD, chronic pain, gastrointestinal issues, and more general somatic complaints. Sleep difficulties played a key role in
bridging PTSD and somatic symptoms. Our network analysis demonstrates the distinct nature of PTSD and somatization symptoms, with
this association connected by disturbed sleep.
Posttraumatic stress disorder (PTSD) is a common and well-
recognized psychiatric disorder that occurs following a trau-
matic event. Lifetime prevalence differs according to trauma
type and varies between 1.3% and 8.8% (Atwoli et al., 2015).
The estimated mean conditional risk of developing PTSD after
any traumatic event is 4.0%, but this risk is much higher for
interpersonal trauma, such as sexual assault and armed com-
bat (Kessler et al., 2017). The disorder is characterized by
symptoms of reexperiencing, avoidance, negative changes in
thoughts and mood, and hypervigilance (American Psychiatric
Association, [APA], 2013). Posttraumatic stress disorder is a
debilitating condition that causes considerable distress and im-
pairment in social, occupational, and interpersonal functioning,
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in addition to significant societal costs (Ferry et al., 2015) and a
wide range of psychiatric and physical health problems (Shalev
et al., 2019).
Common comorbidities with PTSD include substance abuse,
suicide, depression (Bisson et al., 2015), life-limiting infec-
tions (Song et al., 2019), coronary heart disease (Edmondson
et al., 2013), Type 2 diabetes, and autoimmune disease (Scher-
rer et al., 2019), as well as chronic physical symptoms. Individ-
uals with PTSD report poorer physical health-related quality
of life and more gastrointestinal and cardiac problems, mus-
culoskeletal pain, and general health complaints compared to
those without PTSD (Pacella et al., 2013). Between 50% and
80% of individuals with PTSD have chronic physical symp-
toms (i.e., long-lasting abnormal bodily sensations; McAn-
drew et al., 2019), and 9.7% of individuals with chronic phys-
ical symptoms have PTSD, with a particularly high prevalence
among those with chronic pain (20.5%; Siqveland et al., 2017).
One meta-analysis of associations between PTSD and physi-
cal symptoms found an effect size of 0.46 (κ = 16; Pacella
et al., 2013). The comorbidity of PTSD and physical symp-
toms results in poorer prognoses, higher levels of disability,
more severe symptoms, lower treatment engagement, and more
opioid use (McAndrew et al., 2019). The combination of high
prevalence and poorer outcomes suggests common etiological
mechanisms.
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Physicians have traditionally clustered physical symptoms
that cannot be fully medically explained into conditions such
as chronic pain syndrome, irritable bowel syndrome (IBS),
chronic fatigue syndrome, tinnitus, temporomandibular joint
pain, whiplash, headaches, and fibromyalgia (Afari et al.,
2014). Current thinking suggests a significant influence of psy-
chological and social factors whereby there is no clear organic
cause for such distressing somatic complaints (Morina et al.,
2018). The fifth edition of the Diagnostic and Statistical Man-
ual of Mental Disorders (DSM-5; APA, 2013) conceptualizes
medically unexplained symptoms (MUS) as “somatic symptom
disorders” (SSD) and requires the presence of distressing phys-
ical health complaints in association with excessive concern
or preoccupation with somatic symptoms (Afari et al., 2014).
This suggests a large psychobehavioral overlay in a condition
with uncertain physical pathophysiology (Henningsen, 2018),
with considerable personal and societal costs (Konnopka et al.,
2013). Previous conceptualizations of MUS were criticized as
reductive, with an ongoing debate over classification as a singu-
lar syndrome or as separate conditions, thus prompting redefini-
tion within the DSM-5 (Okur Guney et al., 2019). The etiology
of MUS is unclear, but there appears to be a complex interplay
of biological, psychological, and social factors that cause and
maintain bodily distress.
Often, SSDs involve inflammatory or immune-related pro-
cesses, and it is likely that PTSD affects global immune func-
tioning through shifts in neurobiology in the hypothalamic–
pituitary–adrenal (HPA) axis (Song et al., 2019), although we
did not assess this in the current study. Furthermore, cognitive
and behavioral features of PTSD, such as insomnia, depression,
substancemisuse, anxiety sensitivity, avoidant coping, and neg-
ative posttraumatic cognitions may, directly and indirectly, ex-
acerbate somatic symptoms through systemic changes in in-
flammatory and immune functioning (Kendall-Tackett, 2009).
Negative posttraumatic cognitions, such as an individual’s neg-
ative perceptions of themselves and the world, are closely re-
lated to low levels of social support and interpersonal problems
and contribute to the onset and maintenance of PTSD (Alliger-
Horn et al., 2017). These negative cognitions have also been
associated with chronic pain–related impairment (Porter et al.,
2013).
The association between PTSD severity and somatic symp-
tom severity may be bidirectional as they may mutually main-
tain one another (McAndrew et al., 2019) via both psychoso-
cial and biological factors, with PTSD and somatic symptom
comorbidity resulting in a poorer prognosis, more disability,
and poorer treatment outcomes (Sharp & Harvey, 2001). This
relation could also be due to confounding (e.g., related to the
severity of trauma exposure). Both conditions may be indepen-
dently associated with trauma exposure, with neither express-
ing a causal effect on the other.
To date, researchers have only examined this co-occurrence
at a disorder level by investigating either an individual syn-
drome or the broader category of SSD. Previous work has not
provided clear evidence of any specific overlapping symptoms,
which, considering the high comorbid prevalence and common
underlying etiologies, requires investigation. Network analysis
posits that psychiatric disorders result from the complex causal
interplay between symptoms rather than as a result of a dis-
tinct underlying disease entity. We wished to use this network
analysis approach by assessing symptom relatedness to exam-
inewhether there were distinct clusters of PTSD symptoms sep-
arate from physical health symptoms or if there were symptoms
that acted as bridges or boundaries between the disorders.
Network analysis is an exploratory technique that allows re-
searchers to investigate the co-occurrence of these disorders by
examining the direct associations between PTSD and physical
health symptoms. Thus far, network analysis has been used in
traumatic stress research to investigate the associations between
PTSD, anxiety, and depression (Frewen et al., 2013); PTSD
and depression (Afzali et al., 2017); and International Clas-
sification of Diseases (11th rev.; ICD-11) PTSD and complex
PTSD (CPTSD) symptom clusters (Knefel et al., 2019; McEl-
roy et al., 2019). These findings have identified bridge symp-
toms (i.e., symptoms that are important in connecting densely
connected clusters of nodes nested within broader networks),
which may provide insight into potential mechanisms that give
rise to and/or maintain comorbidity and suggest useful targets
for early interventions regarding the development of comorbid-
ity (Afzali et al., 2017).
The aims of the present researchwere to examine the network
structure of somatization and PTSD symptoms and to assess
where and to what degree these symptom domains are related.
This was the first study, to the best of our knowledge, to apply
network analysis to comorbid PTSD and physical health prob-
lems or to somatization more broadly. Although we expected
some clustering of PTSD symptoms, with separate clustering
of somatic items based on affected organ systems, the study re-
mained exploratory with regard to which symptoms would act
as bridges between PTSD and somatization.
Method
Participants and Procedure
Participants in this cross-sectional network analysis were re-
cruited via the National Centre for Mental Health (NCMH),
a government-funded Welsh research center (National Health
System [NHS] Health Research Authority, 2016). The cohort
was a trauma-exposed sample of individuals who self-reported
a current or historical PTSD diagnosis or experienced a trau-
matic event that satisfied DSM-IV Criterion A (Brewin et al.,
2002). All participants in the present sample subsequently
completed the Clinician-Administered PTSD Scale for DSM-5
(CAPS-5), with most screening positive for current PTSD. In-
dividuals who were 16 years of age or older were recruited
through primary and secondary mental health services as well
as through online advertising strategies and a variety of so-
cial media outlets. Due to the risk of exacerbating psycholog-
ical distress, we excluded individuals who had recently been a
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mental health inpatient or were in frequent contact with a crisis-
related intensive home treatment team. We also excluded indi-
viduals who were unable to read and write in English. In total,
196 participants who were contacted refused to participate or
did not attend the initial interview. Of the 355 participants who
completed the initial interview, 349 completed the CAPS-5,
forming our sample. The present study was granted ethical ap-
proval by the Wales Research Ethics Committee 2.
Measures
PTSD Symptoms
We used the CAPS-5 (CAPS-5; Weathers et al., 2018) to as-
sess PTSD symptoms. The CAPS-5 is a clinician-administered
scale and is widely referred to as the gold standard in PTSD as-
sessment (Weathers et al., 2018). The scale measures symptom
severity and intensity, with responses given on a 5-point Lik-
ert scale ranging from 0 (absent) to 4 (extreme/incapacitating).
Reexperiencing symptoms (i.e., Criterion B) are measured as a
sum of the intensity scores for five items. Avoidance symptoms
(i.e., Criterion C) is measured as the sum of the intensity scores
for two items. Negative alterations in cognitions and mood (i.e.,
Criterion D) and alterations in arousal and reactivity (i.e., Cri-
terion E) are measured as the sum of seven items and six items,
respectively. A DSM-5 PTSD diagnosis requires a minimum of
one reexperiencing symptom, one avoidance symptom, and at
least two symptoms relating to negative alterations in cogni-
tion and mood and two symptoms related to hyperarousal. In
addition, the symptoms must have lasted for at least 1 month
and must be causing significant distress or functional impair-
ment. The CAPS-5 has demonstrated high internal consistency
(Cronbach’s α = .88) and strong test–retest reliability (к= .83;
Weathers et al., 2018).
Somatic Symptoms
We used the Patient Health Questionnaire–15 (PHQ-15;
Kroenke et al., 2002) to measure self-reported somatic symp-
tom severity over the past 7 days. Each of the fifteen items on
the PHQ-15 is rated on a 3-point Likert scale ranging from 0
(not bothered at all) to 2 (bothered a lot). The total score is
continuous and can range from 0 to 30; the measure can also
provide a categorical measure of somatic symptom severity. A
total score of 0 to 4 indicates minimal somatic symptom sever-
ity, 5 to 9 indicates low severity, 10 to 14 indicates medium
severity, and 15 to 30 indicates a high level of symptom severity
(Kroenke et al., 2002). The PHQ-15 is well validated and has a
sensitivity of 78% and a specificity of 71% for a DSM-IV diag-
nosis of somatoform disorder in a primary care setting when
using a cutoff score of 3 or more severe somatic symptoms
over the preceding 4 weeks (van Ravesteijn et al., 2009). We re-
moved an item related to menstruation due to a large proportion
ofmale participants in our sample andmissing data from female
participants.
Data Analysis
We used the R package “qgraph” (Epskamp et al., 2012) to
estimate a network using the CAPS-5 and PHQ-15. To avoid
topological overlap, which may upwardly bias the importance
of symptoms within a network (Fried & Cramer, 2017), we
created item parcels by summing items reflecting Criterion
B (reexperiencing), Criterion C (avoidance), Criterion D
(negative alterations in cognition and mood), and Criterion E
(alterations in arousal and reactivity) using the CAPS-5 scores.
In addition, we included 14 of the PHQ-15 items (excluding
Item 4, as noted, which was only applicable to women), each
of which represented a unique somatic symptom. Symptoms in
the network are represented as nodes, and the connecting lines
between the nodes, known as edges, represent the associations
between symptoms. The appropriate correlation matrix was
computed using the cor_auto function in qgraph, and this was
used to estimate a regularized partial correlation network. To
avoid problems associated with multiple testing, we used the
graphical LASSO method to shrink edges and set very small
edges to 0 using the default tuning parameter of 0.5 (Epskamp
et al., 2018). This method produces a sparse network that bal-
ances fit with explanatory power (Epskamp et al., 2018). Edges
within such networks can be interpreted as partial correlations,
controlling for all other variables in the network. Thicker
edges represent stronger associations between nodes. The
Fruchterman–Reingold graphical algorithm arranges nodes
based on how strongly they are associated with one another,
with more weakly correlated nodes placed peripherally in the
network (Epskamp et al., 2012). We tested for modularity using
the “walktrap” algorithm in the Exploratory Graph Analysis
(EGA) R package (Golino & Epskamp, 2017). This function
detects clusters of densely connected nodes that are nested
within the broader network (Figure 1).
To estimate each symptom’s importance within the network,
we examined node centrality (Opsahl et al., 2010). Centrality
refers to the connectivity of symptoms within a network (i.e.,
the number and strength of connections a node has with other
nodes) and is theoretically proposed to denote the importance
and clinical relevance of symptoms within a given network. We
used strength (i.e., the absolute sum of edge weights) as a mea-
sure of node centrality. To determine which nodes were influ-
ential in bridging symptom clusters—if clusters were identified
using the walktrap algorithm, discussed earlier—we calculated
bridge strength. This bridging metric was calculated in a sim-
ilar way to standard centrality measures; however, this metric
focuses solely on connections between clusters. Bridge central-
ity indices were calculated using the R package “networktools”
(Jones et al., 2019). All centrality and bridge centrality indices
were presented as standardized z scores, with higher scores re-
flecting a higher degree of importance within a network.
We used the R package “bootnet” to assess the stability of
individual networks (Epskamp et al., 2018). Bootstrapping
95% confidence intervals around the network edge weights
allows for the estimation of a correlation stability coefficient
Journal of Traumatic Stress DOI 10.1002/jts. Published on behalf of the International Society for Traumatic Stress Studies.
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Figure 1
Network Depiction of Associations Among Posttraumatic Stress Disorder (PTSD) Symptoms and Symptoms Related to Physical Health
Note. Symptoms of PTSD assessed using the Clinician-Administered PTSD Scale for DSM-5; physical health symptoms assessed using the Patient Health
Questionnaire–15. Blue lines represent positive associations, with the thickness of the line indicating association strength. The color of the node represents which of
the four clusters the symptom belongs to as estimated by exploratory graph analysis (testing for modularity). IBS= irritable bowel syndrome; GI= gastrointestinal;
UGI = upper GI; MSK = musculoskeletal.
for centrality metrics, with values above 0.5 implying strong
stability; edge-weight differences; and centrality differences
(Epskamp et al., 2018). We estimated the network using a
pairwise present approach to missing data. To assess whether
the missing data could affect the estimation of the network,
we imputed missing PHQ-15 values using the R package
“missforest” (Supplementary Figure 4).
Results
Of the 349 individuals who completed the CAPS-5, 215
(61.6%) met the DSM-5 diagnostic criteria for PTSD, whereas
134 (38.4%) did not meet the criteria. The demographic
characteristics of the sample are presented in Supplementary
Table 1. Of the 349 CAPS-5 completers, 221 completed all
PHQ-15 items, excluding the menstruation item, with 249–282
individuals completing each item. Regarding somatic symptom
severity, 116 participants (52.5%) scored in the high range,
52 (23.5%) scored in the medium range, 30 (13.6%) scored in
the low range, and 16 (7.2%) had a minimal level of symptom
severity. As explored in Supplementary Table 2, individuals
with PTSD had higher levels of somatic symptom severity than
those without PTSD.
Network Structure
We assessed the stability of the network and the validity
of our findings by estimating the confidence intervals of edge
weights (Fried et al., 2018). This uses a bootstrapping method
that estimates the robustness of the strength centrality measure.
As shown in Supplementary Figure 1, the confidence intervals
were moderately wide, indicating some imprecision of the
network estimation. The correlation stability coefficient for the
strength centrality metric was .361, which is above the cutoff
score of .25 but below the recommended score of .50 as a re-
liable indicator of stability (Epskamp et al., 2018)). Symptom
overlap was assessed using the Goldbricker function in the
networktools R package. Fewer than 25% of the correlations
were significantly different for the following pairs of nodes:
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constipation or diarrhea and stomach pain, avoidance and
reexperiencing, feeling one’s heart pound or race and fainting
spells, pain or problems during sexual intercourse and shortness
of breath, and nausea, gas or indigestion and constipation or
diarrhea. We considered the correlations between these nodes
to represent meaningful connections with one another rather
than redundancy. As items on both the PHQ-15 and the CAPS-
5 (i.e., Items B2 and E6) assess disturbed sleep, we removed
the CAPS-5 items from the network. Both the pairwise present
approach (Figure 1) and the imputation (Supplementary Figure
1) of missing data produced very similar networks.
EGA Clustering
The EGA revealed a four-cluster solution. The first clus-
ter comprised PTSD symptoms, the second comprised chronic
pain symptoms as well as poor sleep, the third comprised gas-
trointestinal symptoms, and the fourth was made up of more
general somatic complaints (Figure 1).
Centrality Analysis and Stability
Centrality and bridge centrality measures are presented in
Figure 2 and Figure 3. Our bootstrapping procedure supported
the robustness of our centrality measures, graph structure, and
edge weights (Supplementary Figures 1, 2, and 3). Fainting
spells, pain or problems during sexual intercourse, and negative
alterations in cognition and mood were the symptoms with the
highest strength centrality. Trouble sleeping and feeling tired
or having low energy were the symptoms highest in most mea-
sures of bridge centrality. The high bridge centrality of sleep
difficulties and tiredness may be derived from the close asso-
ciations between these two symptoms and this may drive the
increased bridge centrality of the “trouble sleeping” node.
Discussion
Through graphical LASSO networks, we were able to iden-
tify distinct traumatic stress and somatization symptom struc-
tures. The network suggests that PTSD and somatic symptoms
form distinct clusters and that sleep difficulty may act as a key
bridge between these domains. Sleep difficulty could be a fun-
damental symptom that exacerbates and maintains PTSD and
somatization comorbidity, but it could also be a consequence
of this comorbidity, thus resulting in a positive correlation. As
sleep was assessed by both of the scales used in the present
study, we removed sleep-related CAPS-5 items to avoid exag-
gerating the perceived importance of sleep within the network
via overlapping measurements. It should be noted, however,
that sleep disturbance is not a feature of DSM-5 SSD (APA
2013).
Sleep disturbance is a core symptom of PTSD, with the
CAPS-5 containing items relating to recurrent distressing
dreams and difficulty falling and staying asleep (APA, 2013),
which are contained within the reexperiencing and arousal
nodes, respectively. Between 70% and 91% of individuals with
Figure 2
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Note. Re = reexperiencing; NACM = negative alterations in cognition and
mood; MSK = musculoskeletal; GI = gastrointestinal; UGI = upper gastroin-
testinal; SoB = shortness of breath; AV = avoidance; AR = arousal.
PTSD report trouble falling or staying asleep, with between
19% and 71% experiencing nightmares (Maher et al., 2006).
Sleep problems are associated with the onset, maintenance, and
worsening of PTSD (Maher et al., 2006). Moreover, 64.9% of
individuals who report somatic complaints also report trouble
sleeping (Hanel et al., 2009), with sleep difficulties accurately
predicting the onset and exacerbation of chronic pain (Finan
et al., 2014). Sleep is broadly associated with poorer psychiatric
outcomes (Krystal, 2012), and thus may indicate global PTSD
and/or somatization severity, with more severe symptoms of ei-
ther PTSD or somatization producingmore severe symptoms of
the other in addition to poorer treatment outcomes (Akerblom
et al., 2017).
There may be causal mechanisms that relate poor sleep to
PTSD and somatization, but uncertainty remains regarding the
direction of causality. Mechanisms by which sleep has a causal
effect on PTSD and somatization include both physical factors,
such as inflammation, and psychological factors, such as cog-
nition. Research has shown that posttraumatic cognitions may
directly, via increasing negative preoccupation and perception
of the somatic symptoms, and indirectly, through effects on
depressive symptomatology and chronic inflammation, exac-
erbate somatic symptoms (Kendall-Tackett, 2009), and sleep
Journal of Traumatic Stress DOI 10.1002/jts. Published on behalf of the International Society for Traumatic Stress Studies.
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Figure 3
Bridge Centrality Strength Network Statistics
may have a key role in this by deleteriously affecting cogni-
tion and worsening catastrophic appraisal of somatic symptoms
(Krystal, 2012). Sleep disturbance is also associated with
higher levels of systematic inflammation, particularly c-
reactive protein and interleukin-6 (Irwin et al., 2016). Some
MUS, such as fibromyalgia, are well known (Littlejohn &
Guymer 2018) to involve immune-related processes, while in-
dividuals with PTSD exhibit significantly elevated levels of
proinflammatory markers, suggestive of HPA axis dysfunction
(Hori & Kim, 2019). Poor sleep may exacerbate systemic im-
mune dysregulation, resulting in increased severity with regard
to symptoms of somatization and PTSD.
The causality of the association between PTSD and somati-
zation is unlikely to be unidirectional, despite the findings from
one study that demonstrated little evidence that the risk of new
PTSD is increased in individuals with preexisting somatization
(Andreski et al., 1998). It seems more likely that the associ-
ation is one of bidirectional mutual maintenance (McAndrew
et al., 2019), involving both psychosocial and biological fac-
tors, which could be mediated by sleep. Posttraumatic cogni-
tions and inflammation may have a key role in this bidirectional
model whereby PTSD may cause worse somatization symp-
toms through poor sleep and, conversely, somatization may
cause more severe PTSD, again via poor sleep.
Our EGA clustered sleep with back pain and pain in the
arms, legs, or joints. Individuals with comorbid chronic pain
and PTSD report more severe pain and pain-related impair-
ment and are more likely to have a high risk of opioid use
(Morasco et al., 2013) compared to those with chronic pain
alone. Between 50% and 88% of individuals with chronic pain
also report insomnia (Wei et al., 2018), whereas 20% report
PTSD—a higher proportion than other somatization syndromes
(Siqveland et al., 2017). Thus, it is not surprising that disturbed
sleep was considered a core symptom in the present network’s
chronic pain cluster, but sleep may also mediate the strong as-
sociations between PTSD and chronic pain that have been re-
ported (Siqveland et al., 2017); our analyses support this strong
association. Another explanation may be that sleep plays a key
mediating role between chronic pain and PTSD, with chronic
pain causing more severe sleep disturbances and thus exacer-
bating PTSD. Our analyses of somatization in adults supports
and builds on previous research highlighting associations be-
tween chronic pain and sleep disturbance in young individuals
(Noel et al., 2018; Pavlova et al., 2020).
The PTSD symptoms of avoidance and hyperarousal had
a neutral or negative strength within the network. This indi-
cates their lack of associations with somatization symptoms.
Negative alterations in cognition and mood and reexperiencing
symptoms, however, demonstrated positive connectivity within
the network.
Judith Herman (1992) previously proposed somatization as
one of six criteria for a diagnosis of “disorders of extreme stress
not otherwise specified” (DESNOS), and although the associ-
ation between physical health complaints and PTSD remains
strong, these findings suggest somatization is not an integral
part of the PTSD diagnosis itself. Our results support the recent
conceptualization of the association between PTSD and somati-
zation illustrated in theDSM-5 PTSD criteria (APA, 2013), with
somatization and physical health problems remaining factors
that are associated with PTSD but not included as core PTSD
symptoms.
Our results support previous validation work regarding the
PHQ-15 (Leonhart et al., 2018), with a confirmatory fac-
tor analysis identifying a bifactor model that included one
general symptom group and four independent organ-specific
symptom groups representing gastrointestinal symptoms, fa-
tigue, cardiopulmonary symptoms, and pain-related symptoms
(Witthoft et al., 2016). We identified a general physical health
cluster, with separate clusters for gastrointestinal symptoms
and chronic pain, and although the EGA analysis did not iden-
tify a specific cardiopulmonary cluster, the three cardiac symp-
toms were strongly associated with one another in the network.
The subjective phenomena of pain can be qualitatively different
across disorders and individuals; thus, stomach pain, chest pain,
and back pain exist within different symptom clusters. These
findings question the unification of psychosomatic problems
within SSD in the DSM-5 (APA, 2013), as, within the present
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sample, we were not able to identify discrete syndromes, al-
though the PHQ-15 does not measure illness-related thoughts,
feelings, and behaviors, which are a key component of the SSD
diagnosis (Henningsen, 2018).
In the present study, we found that individuals with PTSD
reported higher levels of somatic symptom severity than those
without PTSD, and this was likely due to both biological and
psychosocial factors. Physical health problems can be caused
by traumatic events (Gillock et al., 2005), and traumatic stress
reactions themselves can cause long-term shifts in systemic im-
mune functioning, with prolonged somatic health problems a
result of ongoing hyperarousal (Sijbrandij et al., 2015). Un-
healthy and dysfunctional coping strategies, such as tobacco,
alcohol, and drug abuse, can lead to even poorer physical health
(Berenz&Coffey, 2012). Seekingmedical expertise via a phys-
ical health complaint may be more acceptable for some indi-
viduals who are reluctant to disclose their psychiatric symp-
toms due to stigma or because of the characteristic avoidance
of PTSD. It is also possible that individuals with PTSD may
be especially preoccupied with their somatic complaints, and
hyperarousal and anxiety may lead to a catastrophic interpre-
tation of the symptoms or an attentional bias toward negative
symptoms (Bryant et al., 1999).
It is important to acknowledge some limitations to the present
study that should be taken into account when interpreting the re-
sults. First, although the samplewas composed of clinical cases,
it was modest in size (i.e., N = 349), and the confidence inter-
vals of edge weights were imprecise. Furthermore, the poten-
tial for selection bias (e.g., Berkson’s bias; de Ron et al., 2019)
when using clinical samples highlights the need for some cau-
tion in the interpretation of our networks. Due to sample size
limitations, we were unable to assess individual PTSD symp-
toms as separate nodes within the network, and grouping PTSD
symptoms into DSM-5 PTSD criteria may have created an ar-
tificial clustering of these symptoms within the network. Fur-
ther replication using larger sample sizes is required to confirm
our results. The cross-sectional nature of our study prevents the
determination of causality from the investigated associations.
Third, our sample lacked ethnic heterogeneity, with 94% of the
sample reporting their race as White. The results of this net-
work analysis may be specific to our sample population, which
includes a specific cultural context of distress following a trau-
matic event (Gilmoor et al., 2019); thus, it is important to con-
firm these findings in different cultural groups with larger sam-
ples. Our work highlights key avenues for future research, such
as the association of inflammatory biomarkers in the relation
between PTSD and somatization and examinations of causal ef-
fects through intensive longitudinal assessments (Gelkopf et al.,
2018).
The results of our network analysis demonstrate the distinct
nature of PTSD and somatization, with sleep emerging as a
central factor in bridging these disorders. The present results
support the validity of the PHQ-15 as a means to differentiate
between organ-system–related syndromes and the categoriza-
tion of somatization symptoms into these syndromes. Previous
studies have only examined the broad latent constructs within
the framework of comorbid PTSD and somatization. This
was the first study of which we are aware to investigate this
association on an item level. Our analyses offer key insights
into the underlying mechanisms of this clinically important
comorbidity, paving the way for future research aimed at
investigating the role sleep plays in this association.
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